DESIGN DEVELOPMENT AND OPTIMIZATION OF A SUSTAINED RELEASE TABLET OF BOSENTAN MONOHYDRATE FOR PULMONARY ARTERIAL HYPERTENSION
Journal: Indian Drugs (Vol.56, No. 03)Publication Date: 2019-03-28
Authors : Dighe P. P.; Tank H. M;
Page : 61-67
Keywords : ;
Abstract
Pulmonary arterial hypertension (PAH) means high blood pressure in the lungs caused by obstruction in the small arteries of the lungs.The current study involves the fabrication of oral matrix sustained release tablet of bosentan monohydrate, a dual endothelin receptor antagonist, the optimisation of its in vitro release and characterisation. Methocel K4M PremiumDC2, a directly compressible HPMC grade, has been used as the sustained release polymer. Pregelatinised starch is used as a diluent and release modifier and sodium lauryl sulphate as a solubiliser. The influence of the above variables on drug release is measured using a 23 factorial design using design expert software. Surface response plots show significant interaction among the formulation variables, thus aiding in optimization of bilayer tablet.
Other Latest Articles
- BINARY COMPLEXES OF GLIMEPIRIDE WITH β-CYCLODEXTRIN FOR IMPROVED SOLUBILITY AND DRUG DELIVERY
- CHEMOMETRICS ASSISTED STABILITY INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF ACETYL CYSTEINE AND AMBROXOL HYDROCHLORIDE IN BULK AND DOSAGE FORM
- Forced Degradation Studies of Olmesartan medoxomil and Chlorthalidone: Development and Validation of Stability-Indicating RP‑HPLC method
- SIMULTANEOUS ESTIMATION OF DAPAGLIFOZIN AND SAXAGLIPTIN IN TABLETS USING two CHEMOMETRIC-ASSISTED UV-SPECTROPHOTOMETRIC METHODS
- GASTRO-PROTECTIVE POTENTIAL OF FLOWERS OF HIBISCUS ROSA-SINENSIS (L.) IN MUCOSAL LESION ON RATS
Last modified: 2019-04-01 20:10:47